Ingredient Broadcast
The main ingredient of this product is heparin sodium.
Trasit Broadcast
This product is colorless to light yellow clear liquid.
Indication Broadcast
For the prevention and treatment of thrombosis or embolism diseases (such as myocardial infarction, thrombophlebitis, pulmonary embolism, etc.); disseminated intravascular coagulation (DIC) caused by various reasons; also used for hemodialysis, extracorporeal circulation, catheterization, Anticoagulation treatment of certain blood samples or instruments in operations such as microvascular surgery.
Specifications Broadcast
2ml: 12,500 units
Usage and Dosage
1. Deep subcutaneous injection: 5,000-10,000 units for the first time, 8,000-10,000 units every 8 hours or 15,000-20,000 units every 12 hours; the total amount is about 30,000-40,000 units every 24 hours, and generally can achieve satisfactory results.
2. Intravenous injection: After the first 5,000-10,000 units, or 100 units/kg every 4 hours according to body weight, dilute with sodium chloride injection and apply.
3. Intravenous infusion: Add 20,000 to 40,000 units per day to 1,000ml of sodium chloride injection for continuous infusion. Intravenous injection of 5000 units can be used as the initial dose before instillation.
4. Preventive treatment: For patients with high-risk thrombosis, it is mostly used after abdominal surgery to prevent deep vein thrombosis. Give 5000 units of heparin subcutaneously 2 hours before the operation, but epidural anesthesia should be avoided in the way of anesthesia, and then 5000 units every 8 to 12 hours for a total of about 7 days.
Adverse Reaction Broadcast
The toxicity is low, and the main adverse reaction is that excessive medication can cause spontaneous bleeding, so the coagulation time should be measured before each injection. If severe bleeding is caused after the injection, protamine sulfate can be injected intravenously for first aid (1mg protamine sulfate can neutralize 100U heparin).
Occasionally, it can cause allergic reactions and thrombocytopenia often occurs in the first 5 to 9 days of medication, so the platelet count should be monitored regularly within 1 month after starting treatment. Occasionally one-time hair loss and diarrhea. Can still cause osteoporosis and spontaneous fractures. Long-term use in patients with poor liver function can cause depletion of antithrombin- and thrombosis tendency.